Founded in 2022 and headquartered in Shenzhen, Guangdong China, BayOmics is a company that specializes in the development of biological and pharmaceutical technology for the treatment of critical illnesses. With a focus on innovative solutions, BayOmics aims to address the pressing medical needs of patients by leveraging advanced scientific research and cutting-edge technology. By developing novel treatments and therapies, the company aims to improve patient outcomes and contribute to the advancement of healthcare.